Comparison Study of Insulin GZR4 With Insulin Degludec
Status:
RECRUITING
Trial end date:
2026-06-01
Target enrollment:
Participant gender:
Summary
In this study, the investigational product will be compared with insulin degludec (Tresiba) and insulin icodec (Awiqli). The comparator products are approved for the treatment of T2DM in the European Union.